Stocks and Investing Stocks and Investing
Fri, December 13, 2019

Alethia Young Maintained (SRPT) at Buy with Increased Target to $211 on, Dec 13th, 2019


Published on 2024-10-26 19:04:51 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Cantor Fitzgerald, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $175 to $211 on, Dec 13th, 2019.

Alethia has made no other calls on SRPT in the last 4 months.



There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 0 agree with Alethia's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Alethia


  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $167 on, Monday, November 18th, 2019
  • Whitney Ijem of "Guggenheim" Initiated at Strong Buy and Held Target at $183 on, Friday, November 1st, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $160 on, Friday, October 11th, 2019
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $181 on, Tuesday, August 20th, 2019
Contributing Sources